Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
HMP.TO 0.03SPGP 1ZUQ.TO 0.55NVDA 0.32GL 1.66MRK -1.71IEMG 0.5GEV 33.87
Daily Stock Opinions and Ratings
Stockchase Opinions

Peter HodsonAfexa Life Sciences Inc.FXA.TODON'T BUYDec 20, 2004

Stock has had a huge run. Huge growth opportunity.Product ColdFX seems to be working very well. Negative is that it is trading at about 31 X sales. Very high risk.
Peter HodsonPeter Hodson
No
Unlock Rating
$2.51

Stock price when the opinion was issued

biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
Get Signals Create your Watchlist
Track your Stocks in your Watch List

You might be interested:

COMMENT

Afexa Life Sciences Inc.(FXA.TO)

Mar 12, 2007
A marketing company. A little bit of controversy. Want to label their product in the US. Never enthralled with marketing companies. Costs a lot of money and you are at the mercy of the vagueness of the consumer.
Photo of Peter HodsonPeter Hodson
No
Unlock Rating
$2.49

Stock price when the opinion was issued

biotechnologypharmaceutical
HOLD

Afexa Life Sciences Inc.(FXA.TO)

Feb 26, 2007
Manufactures ColdFX. Loves the product, but a little concerned about the share price. Revenues are considerably smaller than the market cap. A little ahead of itself.
Photo of Michael DecterMichael Decter
No
Unlock Rating
$2.40

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Afexa Life Sciences Inc.(FXA.TO)

Dec 28, 2006
Started launching ColdFX in the US and want to go through the full trial process to get approval as to what they can claim on the product. Expensive stock.
Photo of Peter HodsonPeter Hodson
No
Unlock Rating
$2.81

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Afexa Life Sciences Inc.(FXA.TO)

Nov 02, 2006
Had a long drop from December to May which was followed by a number of upward steps. Those are very important levels and he thinks the stock probably has more positive news in it. Every time there is a rally, there is a lot of volume with it.
Photo of Jeff Parent B. Eng. FCSI CIMJeff Parent B. Eng. FCSI CIM
No
Unlock Rating
$3.98

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Afexa Life Sciences Inc.(FXA.TO)

Mar 01, 2005
Great product. Watch for fads. Great marketing company.
Photo of Peter HodsonPeter Hodson
No
Unlock Rating
$2.84

Stock price when the opinion was issued

biotechnologypharmaceutical
WATCH

Afexa Life Sciences Inc.(FXA.TO)

Feb 24, 2005
A very interesting company. Using ginseng extract to create a remedy for colds. (ColdFX) The product has just taken off. Still looking at it. If they go into the US, it could be a big boost. Might be a little expensive here.
Photo of Jean-Francois TardifJean-Francois Tardif
No
Unlock Rating
$2.63

Stock price when the opinion was issued

biotechnologypharmaceutical

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

EPD -0.03$37.25
ET 0.31$19.07
MAIR 0$
RKLB -12.39$102.39
SESG-O 0$

Today's Top Picks

HMP.TO 0.03$9.75
SPGP 1$120.39
ZUQ.TO 0.55$107.47
NVDA 0.32$205.19
GL 1.66$166.76

Popular Articles

Latest Sell Signals

PRGO 0.09$10.99
CBRS 0$
HAWK 0$
AVEX 0$
SWMR 0$

Most Recent Experts

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

Richard Orrell

Richard Orrell

RN Croft Financial Group

Stockchase Insights

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Stan Wong

Private Wealth Management, ScotiaMcleod

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica